Flucelvax Injection, Suspension
Product Images NDC 70461-656

2 FDA label images from Seqirus Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flucelvax (NDC 70461-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – 0.5 mL Carton Label (Flu2t 0016 01)

Principal Display Panel – 0.5 mL Carton Label (Flu2t 0016 01)
Packaging label for Flucelvax 2026-2027 Formula, an influenza vaccine in 0.5 mL single-dose pre-filled syringes. The label indicates it is for intramuscular use, contains ten doses per package, and is manufactured and distributed by Seqirus Inc. It lists vaccine strains and storage instructions on the carton.*
FDA Label Image

Principal Display Panel – 0.5 mL Syringe Label (Flu2t 0016 02)

Principal Display Panel – 0.5 mL Syringe Label (Flu2t 0016 02)
Label for Flucelvax influenza vaccine 2026-2027 formula, injection suspension for intramuscular use. The label states a 0.5 mL dose for ages 6 months and older. Manufactured by Seqirus Inc. The label includes the US license number 2049 and NDC 70461-656-04. Lot and expiration date fields are present but not filled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.